Identification of a CDK4 R24H mutation-positive melanoma family by analysis of early-onset melanoma patients in Latvia

Melanoma Research

Volumn 19, Issue 2, 2009, Pages 119-122

  Pjanova, Dace ^a   Molven, Anders ^d,e   Akslen, Lars A ^d,e   Engele, Ludmila ^b   Streinerte, Baiba ^b   Azarjana, Kristine ^a,c   Heisele, Olita ^a  

^a LATVIAN BIOMEDICAL RESEARCH AND STUDY CENTRE   (Latvia)

^b Latvian Oncological Center   (Latvia)

^c RIGA STRADINS UNIVERSITY   (Latvia)

^d UNIVERSITY OF BERGEN   (Norway)

^e HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CDK4 PROTEIN, HUMAN; DNA;

ADULT; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; CODON; FAMILY HISTORY; FEMALE; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; LATVIA; MALE; MELANOMA; MICROSATELLITE MARKER; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ADOLESCENT; AMINO ACID SUBSTITUTION; CHILD; ETHNOLOGY; GENETICS; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; ONSET AGE; POINT MUTATION; SECOND CANCER; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; AGE OF ONSET; AMINO ACID SUBSTITUTION; CHILD; CYCLIN-DEPENDENT KINASE 4; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; GENES, P16; HAPLOTYPES; HUMANS; LATVIA; MALE; MELANOMA; MUTATION, MISSENSE; NEOPLASMS, SECOND PRIMARY; POINT MUTATION; YOUNG ADULT;

EID: 65449116099     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/CMR.0b013e3283287d3e     Document Type: Article

References (12)

1. De Vries E, Bray FI, Eggermont AM, Coebergh JW, European Network of Cancer Registries. Monitoring stage-specific trends in melanoma incidence across Europe reveals the need for more complete information on diagnostic characteristics. Eur J Cancer Prev 2004; 13:387-395.
2. Goldstein AM, Chan M, Harland M, Hayward NK, Demenais F, Timothy Bishop D, et al. Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents. J Med Genet 2007; 44:99-106.
3. Zuo L, Weger J, Yang Q, Goldstein AM, Tucker MA, Walker GJ, et al. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nat Genet 1996; 12:97-99.
4. Soufir N, Avril MF, Chompret A, Demenais F, Bombled J, Spatz A, et al. The French Familial Melanoma Study Group. Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. Hum Mol Genet 1998; 7:209-216.
5. Soufir N, Ollivaud L, Bertrand G, Lacapère JJ, Descamps V, Vitoux D, et al. A French CDK4-positive melanoma family with a co-inherited EDNRB mutation. J Dermatol Sci 2007; 46:61-64.
6. Molven A, Grimstvedt MB, Steine SJ, Harland M, Avril MF, Hayward NK, et al. A large Norwegian family with inherited malignant melanoma, multiple atypical nevi, and CDK4 mutation. Genes Chromosomes Cancer 2005; 44 :10-18.
7. Pjanova D, Heisele O, Engele L, Randerson-Moor JA, Harland M, Bishop DT, et al. CDKN2A and CDK4 variants in Latvian melanoma patients: analysis of a clinic-based population. Melanoma Res 2007; 17 :185-192.
8. Majore S, De Simone P, Crisi A, Eibenschutz L, Binni F, Antigoni I, et al. CDKN2A/CDK4 molecular study on 155 Italian subjects with familial and/or primary multiple melanoma. Pigment Cell Melanoma Res 2008; 21 :209-211.
9. Coleman KG, Wautlet BS, Morrissey D, Mulheron J, Sedman SA, Brinkley P, et al. Identification of CDK4 sequences involved in cyclin D1 and p16 binding. J Biol Chem 1997; 272:18869-18874.
10. Goldstein AM, Chidambaram A, Halpern A, Holly EA, Guerry D IV, Sagebiel R, et al. Rarity of CDK4 germline mutations in familial melanoma. Melanoma Res 2002; 12:51-55.
11. Stratigos AJ, Yang G, Dimisianos R, Nicolaou V, Stefanaki I, Katsambas AD, et al. Germline CDKN2A mutations among Greek patients with early-onset and multiple primary cutaneous melanoma. J Invest Dermatol 2006; 126:399-401.
12. Tsao H, Zhang X, Kwitkiwski K, Finkelstein DM, Sober AJ, Haluska FG. Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma. Arch Dermatol 2000; 136:1118-1122.